THE ROLE OF MULTIPARAMETRIC MRI IN MEN WITH NEGATIVE BIOPSY AND ELEVATED PSA - CAN IT RULE OUT CLINICALLY SIGNIFICANT DISEASE?

Source of Funding: Mohamed Abd Alazeez receives funding from the Egyptian government. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, Pelican Cancer Foundation, Prostate UK, St Peter's Trust, Prostate Cancer Research Foundation and Prostate Cancer Research Centre. Mark Emberton receives research support from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.